Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2026-06-15 @ 6:06 AM
Study NCT ID:
NCT01286935
Status:
COMPLETED
Last Update Posted:
2011-01-31
First Post:
2010-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD
Sponsor:
Newron Pharmaceuticals SPA
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Parkinson's Disease | View |